StockTimes - Categories

Category: Pharmaceuticals

Pharmaceuticals • 28.04.25

Merck Acquires US Cancer Specialist Springworks in $3 Billion Deal

Merck acquires Springworks Therapeutics for $3 billion, boosting its oncology pipeline with innovative cancer treatments. A game-changer for rare disease therapies.

StockTimes Content Team

Previous 1 Next

Migration • 06.03.25

Understanding the Delays in Germany's Asylum Procedures in 2024

StockTimes Content Team

Finance • 25.04.25

European Markets Poised for Gains as Global Trade Optimism Grows

StockTimes Content Team

Geopolitics • 01.04.25

Finland’s Potential Exit from the Ottawa Treaty: Implications for Global Security

StockTimes Content Team

Finance • 14.04.25

European Stocks Rally as Tech Tariff Exemption Sparks Market Optimism

StockTimes Content Team

Healthcare • 05.03.25

Amazon's One Medical CEO Steps Down: A Shift in Leadership and Healthcare Strategy

StockTimes Content Team

Finance • 11.03.25

HelloFresh Disappoints with Outlook, Henkel Announces Share Buyback, and Gea Raises Dividend

StockTimes Content Team

Space • 18.03.25

Boeing Starliner Astronauts Return to Earth After Extended Stay on ISS

StockTimes Content Team

Geopolitics • 19.04.25

Iran-U.S. Nuclear Talks in Rome: A Pivotal Moment for Global Diplomacy

StockTimes Content Team

Geopolitics • 01.04.25

Finland’s Potential Exit from the Ottawa Treaty: Implications for Global Security

StockTimes Content Team

Geopolitics • 26.04.25

Ukraine War Update: Potential Peace Plan Concessions and Diplomatic Shifts

StockTimes Content Team

Politics • 26.04.25

Germany’s Coalition Talks: Key Reforms and Economic Outlook

StockTimes Content Team

Energy • 09.04.25

Gas Prices Plummet by 12% Amid US-EU Trade Dispute: What It Means for the Market

StockTimes Content Team

Category: Pharmaceuticals

StockTimes Content Team

Categories

Tags